SCHEMBL6969449

SCHEMBL6969449

COC(=O)NCCC=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13310418 0.86 EPHX1 (0.55) —
SCHEMBL16486494 0.85 EPHX1 (0.59) —
SCHEMBL3190326 0.84 EPHX1 (0.61) —
SCHEMBL23703828 0.83 EPHX1 (0.62) —
SCHEMBL16486265 0.80 ACHE (0.44) —
SCHEMBL13258963 0.79 — —
SCHEMBL6538861 0.79 SMN1; SMN2 (0.49) —
SCHEMBL8004 0.79 TDP1 (0.55) —
SCHEMBL7351535 0.77 ACHE (0.55) —
SCHEMBL10243672 0.76 EPHX1 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140221282-A1 LONG DURATION DUAL HORMONE CONJUGATES ASTRAZENECA PHARMACEUTICALS LP 2014-08-07 — — US disclosed
CN-102822175-A 5, 5-fused arylene or heteroarylene hepatitis C virus inhibitors IDENIX PHARMACEUTICALS INC (US) 2012-12-12 — — CN disclosed
CN-101258147-A 4-piperazin-1-yl-4-benzo [ B ] thiophene derivatives for the treatment of CNS disorders OTSUKA PHARMA CO LTD (JP) 2008-09-03 — — CN disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 — — EP disclosed
Send feedback